Skip to main content
ALBT
NASDAQ Life Sciences

Avalon GloboCare 股东批准未来反向股票拆分授权

feedReported by Reuters
Sentiment info
Neutral
Importance info
7
Price
$0.496
Mkt Cap
$3.741M
52W Low
$0.42
52W High
$5.28
Market data snapshot near publication time

summarizeSummary

Avalon GloboCare Corp. 的股东已批准董事会实施未来反向股票拆分的权力。据路透社报道,基于 SEC 的文件,这一授权是在公司最近披露了 1810 万美元巨额净亏损之后做出的。虽然这一批准并不意味着反向股票拆分将立即实施或计划,但它为公司提供了灵活性,以应对潜在的上市要求或促进未来资本事件。对于像 Avalon GloboCare 这样的微型上市公司来说,这是一个重要的公司治理发展,交易者会密切关注,特别是考虑到最近的财务表现和随后的 8-K 文件确认此事件。

在该公告发布时,ALBT的交易价格为$0.50,交易所为NASDAQ,所属行业为Life Sciences,市值约为$374.1万。 52周交易区间为$0.42至$5.28。 这则新闻被评估为中性市场情绪,重要性评分为7/10。 来源:Reuters。


show_chartPrice Chart

Share this article

Copied!

feed ALBT - Latest Insights

ALBT
Apr 21, 2026, 4:30 PM EDT
Filing Type: 8-K/A
Importance Score:
9
ALBT
Apr 21, 2026, 8:30 AM EDT
Filing Type: 8-K
Importance Score:
7
ALBT
Apr 20, 2026, 5:10 PM EDT
Filing Type: 424B3
Importance Score:
9
ALBT
Apr 17, 2026, 5:23 PM EDT
Filing Type: DEFA14A
Importance Score:
9
ALBT
Apr 17, 2026, 5:23 PM EDT
Filing Type: DEF 14A
Importance Score:
10
ALBT
Apr 17, 2026, 4:10 PM EDT
Filing Type: 8-K
Importance Score:
9
ALBT
Apr 08, 2026, 5:19 PM EDT
Filing Type: S-1
Importance Score:
9
ALBT
Apr 02, 2026, 4:27 PM EDT
Filing Type: PRE 14A
Importance Score:
9
ALBT
Apr 01, 2026, 8:38 AM EDT
Source: Reuters
Importance Score:
7
ALBT
Apr 01, 2026, 8:30 AM EDT
Filing Type: 8-K
Importance Score:
7